CHI Pharmaceuticals

CHI Pharmaceuticals is a leading pharmaceutical manufacturing and distribution company based in Lagos, Nigeria. Established in 1990 as part of the Tropical General Investments (TGI) Group, the company became a subsidiary of Fosun Pharma in 2017 following a majority stake acquisition. CHI Pharmaceuticals operates a state-of-the-art manufacturing plant that produces a wide range of essential medicines, including anti-infectives, cardiovascular drugs, and analgesics. The company is well-regarded for its "Chimal" brand of antimalarials and its extensive distribution network that serves the West African market. Additionally, it acts as a local representative and distributor for several global pharmaceutical giants, facilitating access to specialized healthcare products in the region. The company's facilities are designed to meet international quality standards, supporting its mission to provide affordable and high-quality healthcare solutions.